認知症のリスクと認知機能における遺伝的傾向,血代謝体と地中海食事の相互作用
PubMedで要約を見る
まとめ
この要約は機械生成です。アルツハイマー病のリスクは遺伝的構成によって変化し,APOE4遺伝子型によって認知症に影響を与える特定の代謝産物があります. 地中海ダイエットと同様に 精密な栄養は アルツハイマー病やそれに関連する認知症の 標的型予防戦略を提供することができます
科学分野
- 神経科学
- 遺伝学
- メタボロミクス
背景
- アルツハイマー病 (AD) とADに関連する認知症 (AD/ADRD) には重要な遺伝的要素があります.
- APOE4ホモジゴットは認知症のリスクに影響を与える独特の遺伝子サブタイプを表しています.
研究 の 目的
- AD/ADRDの遺伝子型特有の代謝経路と変更可能な危険因子を特定する.
- 認知症のリスクにおける遺伝子変異,血代謝,食事パターンとの相互作用を探求する.
主な方法
- 大規模な前向きなコホート (4,215人の女性,1,490人の男性) の遺伝子,血代謝,および食事データを統合した.
- APOE4遺伝子型および他のAD/ADRDリスク変異体によって層分かれ,57の代謝産物と認知症リスクとの関連を分析した.
- メタボリートと認知結果の因果関係を推論するためにメンデルのランダム化を用いた.
主要な成果
- APOE4遺伝子型によって,認知症のリスクと代謝物質の関連性は著しく変化した.
- コレステリルエステルとスフィンゴミエリンは,APOE4同位体における認知症リスクの上昇と関連しており,グリセリドは,この群に特異的な逆の関連性を示した.
- APOE4 ホモジゴートにおいて,地中海食の遵守により,認知症に関連する代謝物質がより効果的に調節され,19の推定的因果代謝物質と認知的結果の関係が特定された.
結論
- 認知健康に関連する代謝プロファイルは遺伝子型に依存しています.
- 遺伝子プロファイルに合わせた 精密な栄養戦略は AD/ADRDの予防に有望です
- メタボロミックデータは 認知症リスクの予測を わずかに改善できます 特に早期の追跡段階でです
関連する概念動画
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...

